Sung H,Ferlay J,Siegel RL,Laversanne M,Soerjomataram I,Jemal A .2021 .GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin, 10(3) : 209-49.
Bray F,Ferlay J,Soerjomataram I,Siegel RL,Torre LA,Jemal A .2018 .GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 10(6) : 394-424.
Pavlova NN,Thompson CB .2015 .The emerging hallmarks of cancer metabolism. Cell Metab, 12(1) : 27-47.
Hanahan D. .2022 .Hallmarks of cancer: New dimensions. Cancer Discov, 21(1) : 2159-8290.
.2017 .m e s M V , K o r p e l a M A , S m i t h G D . M e n d e l i a n randomisation in cardiometabolic disease: Challenges in evaluating causality. Nat Rev Cardiol, 78(10) : 577-90.
Gupta V,Walia GK,Sachdeva MP .2016 .Mendelian randomisation: An approach for exploring causal relations in epidemiology. Public Health, 12 : 113-9.
Yarmolinsky J,Wade KH,Richmond RC,Langdon RJ,Bull CJ,Tilling KM .2018 .Causal inference in cancer epidemiology: What is the role of mendelian randomisation?. Cancer Epidemiol Biomarkers Prev, 17(9) : 1055-9965.
Inamura K. .2018 .Colorectal cancers: An update on their molecular pathology. Cancers, 10(1) : 26.
Li AM,Ye J .2020 .Reprogramming of serine, glycine and onecarbon metabolism in cancer. Biochim Biophys Acta Mol Basis Dis, 165841 : 165841.
Villar VH,Nguyen TL,Delcroix V,Teres S,Bouchecareilh M,Salin B .2017 .mTORC1 inhibition in cancer cells protects from glutaminolysis-mediated apoptosis during nutrient limitation. Nat Commun, 10 : 14124.
Peyraud F,Guegan JP,Bodet D,Cousin S,Bessede A,Italiano A .2022 .Targeting tryptophan catabolism in cancer immunotherapy era: Challenges and perspective. s Front Immunol, 807271 : 807271.
Nedeva C. .2021 .In ammation and cell death of the innate and adaptive immune system during sepsis. Biomolecules, 10(7) : 1011.
Calder PC .2017 .Omega-3 fatty acids and in ammatory processes: From molecules to ma. Biochem Soc Trans, 10(5) : 1105-15.
Larrauri AG,Presa N,Herrera AD,Ouro A,Trueba M,Munoz AG .2020 .Role of bioactive sphingolipids in physiology and pathology. Essays Biochem, 10(3) : 579-89.
Paul S,Lancaster GI,Meikle PJ .2019 .Plasmalogens: A potential therapeutic target for neurodegenerative and cardiometabolic disease. Prog Lipid Res, 74 : 186-95.
.2019 .. , 04 : .
Lee WJ .2019 .Vitamin c in human health and disease: E ects, mechanisms of action, and new guidance on intake. , : .
Ziberna L,Praznikar ZJ,Petelin A .2021 .Serum bilirubin levels in overweight and obese individuals: The importance of antiin ammatory and antioxidant responseAsn. tioxidants (Basel), 10(9) : 1352.
Dicks LMT .2024 .How important are fatty acids in human health and can they be used in treating diseases?. Gut Microbes, 2420765(1) : 2420765.
Sugimoto MA,Sousa LP,Pinho V,Perretti M,Teixeira MM .2016 .Resolution of in ammation: What controls its onsetF?ront. Immunol, 00160 : 160.
Wishart DS .2016 .Emerging applications of metabolomics in drug discovery and precision medicine. Nat Rev Drug Discov, 32(7) : 473-84.
Li Y,Lin Q,Lu X,Li W. .2021 .Post-diagnosis use of antioxidant vitamin supplements and breast cancer prognosis: A systematic review and meta-analysis. Clin Breast Cancer, 09(6) : 477-85.
Skriver C,Maltesen T,Dehlendor C,Skovlund CW,Schmidt M,Sorensen HT .2024 .Long-term aspirin use and cancer risk: A 20-year cohort study. J Natl Cancer Inst, 10(4) : 530-8.
Llido JP,Jayanti S,Tiribelli C .2023 .Gazzin S. Bilirubin and redox stress in age-related brain diseases. Antioxidants, 10(8) : 1525.